Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C.

× No keyword cloud information.

7 in total

1. Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials.

Authors: R L Carithers; S S Emerson
Journal: Hepatology Date: 1997-09 Impact factor: 17.425

2. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

Authors: E Kenny-Walsh
Journal: N Engl J Med Date: 1999-04-22 Impact factor: 91.245

3. Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C.

Authors: Sean D Sullivan; Antonio Craxi; Alfredo Alberti; Giovanni Giuliani; Claudio De Carli; Neil Wintfeld; Kavita K Patel; Jesse Green
Journal: Pharmacoeconomics Date: 2004 Impact factor: 4.981

4. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Authors: Michael W Fried; Mitchell L Shiffman; K Rajender Reddy; Coleman Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moises Diago; Giampiero Carosi; Daniel Dhumeaux; Antonio Craxi; Amy Lin; Joseph Hoffman; Jian Yu
Journal: N Engl J Med Date: 2002-09-26 Impact factor: 91.245

Review 5. NIH Consensus Statement on Management of Hepatitis C: 2002.

Authors:
Journal: NIH Consens State Sci Statements Date: 2002 Jun 10-12

6. Hematologic disorders associated with hepatitis C virus infection and their management.

Authors: Douglas T Dieterich; Jerry L Spivak
Journal: Clin Infect Dis Date: 2003-08-01 Impact factor: 9.079

7. Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis C.

Authors: S Zeuzem; G Teuber; U Naumann; T Berg; J Raedle; S Hartmann; U Hopf
Journal: Hepatology Date: 2000-10 Impact factor: 17.425

7 in total